@article{eron:hal-02615274,
  TITLE = {{Week 96 efficacy and safety results of the phase 3, randomized EMERALD trial to evaluate switching from boosted-protease inhibitors plus emtricitabine/tenofovir disoproxil fumarate regimens to the once daily, single-tablet regimen of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in treatment-experienced, virologically-suppressed adults living with HIV-1}},
  AUTHOR = {Eron, Joseph and Orkin, Chloe and Cunningham, Douglas and Pulido, Federico and Post, Frank and Wit, St{\'e}phane De and Lathouwers, Erkki and Hufkens, Veerle and Jezorwski, John and Petrovic, Romana and Brown, Kimberley and Landuyt, Erika Van and Opsomer, Magda and Florence, E. and Moutschen, M. and Wijngaerden, E.Van and Gil, I.Santos and Vente, J.De and Vandekerckhove, Linos and Vandercam, Bernard and Brunetta, Jason and Conway, Brian and Klein, Marina and Murphy, Donald and Rachlis, Anita and Shafran, Stephen and Walmsley, Sharon and Ajana, Faiza and Cotte, Laurent and Girardy, P-M and Katlama, Christine and Molina, Jean Michel and Poizot-Martin, Isabelle and Raffi, Francois and Rey, David and Reynes, Jacques and Teicher, Elina and Yazdanpanah, Yazdan and Gasiorowski, Jacek and Halota, Waldemar and Horban, Andrzej and Piekarska, Anna and Witor, Adam and Arribas, Jose R and Perez-Valero, Ignacio and Berenguer, Juan and Casado, Jl and Gatell, Jose and Guti{\'e}rrez, F{\'e}lix and Galindo, Maria-Jos{\'e} and Gutierrez, Maria del Mar and Iribarren, Jos{\'e} Antonio and Knobel, Hernando and Negredo, Eugenia and Pineda, Juan A and Podzamczer, Daniel and Sogorb, J.Portilla and Ricart, C and Rivero, Antonio and Santos-Gil, Ignacio and Blaxh{\"u}lt, Anders and Flamholc, Leo and Gissl{\'e}n, Magnus and Thalme, Anders and Fehr, Jan and Rauch, Andri and Stoeckle, Marcel and Clarke, Amanda B and Gazzard, Brian and Johnson, Margaret and Ustianowski, Andrew and Waters, Laura and Bailey, Justin R and Benson, Paul and Bhatti, Laveeza and Brar, Indira and Bredeek, Ulf and Brinson, Cynthia and Crofoot, Gordon and Dejesus, Edwin and Dietz, Craig and Dretler, Robin and Felizarta, Franco and Fichtenbaum, Carl and Gallant, Joel and Gathe, Joseph and Hagins, Debbie and Henn, Sarah and Henry, Wk and Huhn, Gregory D and Jain, Mamta and Lucasti, Christopher and Martorell, Claudia and Mcdonald, Cheryl and Mills, Anthony and Morales-Ramirez, Javier and Mounzer, Karam and Nahass, Ronald and Olivet, Hannah and Osiyemi, Olayemi and Prelutsky, David and Ramgopal, Moti and Rashbaum, Bruce and Richmond, Gary and Ruane, Peter and Scarsella, Anthony and Scribner, Anita and Shalit, Peter and Shamblaw, David and Slim, Jihad and Tashima, Karen and Voskuhl, Gene and Ward, Douglas J and Wilkin, Aimee},
  URL = {https://amu.hal.science/hal-02615274},
  JOURNAL = {{Antiviral Research}},
  PUBLISHER = {{Elsevier Masson}},
  VOLUME = {170},
  PAGES = {104543},
  YEAR = {2019},
  MONTH = Oct,
  DOI = {10.1016/j.antiviral.2019.104543},
  KEYWORDS = {Darunavir/cobicistat/emtricitabine/TAF ; Single-tablet regimen ; Safety ; Efficacy ; Switch study},
  PDF = {https://amu.hal.science/hal-02615274/file/1-s2.0-S0166354219302475-main%20%281%29.pdf},
  HAL_ID = {hal-02615274},
  HAL_VERSION = {v1},
}